ProScreen 6 Panel Cassette w/Adult (AU), Item No. PSPA-6MBAU

FDA Device Recall #Z-0525-2016 — Class III — November 16, 2015

Recall Summary

Recall Number Z-0525-2016
Classification Class III — Low risk
Date Initiated November 16, 2015
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Ameditech Inc
Location San Diego, CA
Product Type Devices
Quantity 60 kits

Product Description

ProScreen 6 Panel Cassette w/Adult (AU), Item No. PSPA-6MBAU

Reason for Recall

Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.

Distribution Pattern

Nationwide Distribution.

Lot / Code Information

G150179

Other Recalls from Ameditech Inc

Recall # Classification Product Date
Z-3051-2020 Class II Drug Screening Component: Uncut Sheets Part Nu... Aug 18, 2020
Z-3032-2020 Class II CLIA Waived Rapid Drug Test (AMT Item Number/ ... Aug 18, 2020
Z-3044-2020 Class II TDDA Drugs of Abuse Cup(AMT Item/ AMT Descripti... Aug 18, 2020
Z-3036-2020 Class II ImmuTest Drugs of Abuse Cup (AMT Item Number/ A... Aug 18, 2020
Z-3039-2020 Class II Noble 1 Step+ Cup (AMT Item Number/ AMT Descrip... Aug 18, 2020

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.